PCM1-JAK2 fusion in myeloproliferative disorders and acute erythroid leukemia with t(8;9) translocation

被引:80
作者
Murati, A
Gelsi-Boyer, V
Adélaïde, J
Perot, C
Talmant, P
Giraudier, S
Lodé, L
Letessier, A
Delaval, B
Brunel, V
Imbert, M
Garand, R
Xerri, L
Birnbaum, D
Mozziconacci, M
Chaffanet, M
机构
[1] Inst J Paoli I Calmettes, Dept Mol Oncol, Inst Cancerol, F-13009 Marseille, France
[2] INSERM, U599, Marseille, France
[3] Inst J Paoli I Calmettes, Dept BioPathol, F-13009 Marseille, France
[4] Univ Mediterranee, Marseille, France
[5] Hop St Antoine, Lab Cytogenet, F-75571 Paris, France
[6] CHU Nantes, Hotel Dieu, Hematol Lab, F-44035 Nantes, France
[7] Hop Henri Mondor, Serv Hematol, F-94010 Creteil, France
[8] Ctr Hop Pays Aix, Serv Hematol, Aix En Provence, France
[9] Hop Henri Mondor, Hematol Lab, F-94010 Creteil, France
关键词
D O I
10.1038/sj.leu.2403879
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1692 / 1696
页数:6
相关论文
共 5 条
[1]  
BOUSQUET M, 2005, IN PRESS ONCOGENE
[2]   A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].
James, C ;
Ugo, V ;
Le Couédic, JP ;
Staerk, J ;
Delhommeau, F ;
Lacout, C ;
Garçon, L ;
Raslova, H ;
Berger, R ;
Bennaceur-Griscelli, A ;
Villeval, JL ;
Constantinescu, SN ;
Casadevall, N ;
Vainchenker, W .
NATURE, 2005, 434 (7037) :1144-1148
[3]   A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia [J].
Lacronique, V ;
Boureux, A ;
DellaValle, V ;
Poirel, H ;
Quang, CT ;
Mauchauffe, M ;
Berthou, C ;
Lessard, M ;
Berger, R ;
Ghysdael, J ;
Bernard, OA .
SCIENCE, 1997, 278 (5341) :1309-1312
[4]   Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia [J].
Peeters, P ;
Raynaud, SD ;
Cools, J ;
Wlodarska, I ;
Grosgeorge, J ;
Philip, P ;
Monpoux, F ;
VanRompaey, L ;
Baens, M ;
VandenBerghe, H ;
Marynen, P .
BLOOD, 1997, 90 (07) :2535-2540
[5]   The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2 [J].
Reiter, A ;
Walz, C ;
Watmore, A ;
Schoch, C ;
Blau, I ;
Schlegelberger, B ;
Berger, U ;
Telford, N ;
Aruliah, S ;
Yin, JA ;
Vanstraelen, D ;
Barker, HF ;
Taylor, PC ;
O'Driscoll, A ;
Benedetti, F ;
Rudolph, C ;
Kolb, HJ ;
Hochhaus, A ;
Hehlmann, R ;
Chase, A ;
Cross, NCP .
CANCER RESEARCH, 2005, 65 (07) :2662-2667